Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates

Mucosal Immunology

Volumn 6, Issue 4, 2013, Pages 787-796

  Warfel, J M ^a   Merkel, T J ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; MEMORY CELL; MUCOSAL IMMUNITY; NASOPHARYNX; NONHUMAN; PAPIO ANUBIS; PERTUSSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH17 CELL;

EID: 84879407053     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.117     Document Type: Article

References (49)

1. Mattoo, S. & Cherry, J.D. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18, 326-382 (2005).
2. Heininger, U. Updateonpertussis inchildren. Expert. Rev. Anti. Infect. Ther. 8, 163-173 (2010).
3. WHO. Pertussis vaccines: WHO position paper. Wkly. Epidemiol. Rec. 85, 385-400 (2010).
4. Clark, T.A., Messonnier, N.E. & Hadler, S.C. Pertussis control: time for something new?. Trends Microbiol. 20, 211-213 (2012).
5. CDC. Provisional cases of selected notifiable diseases. Morbidity Mortality Wkly. Rep. 59, 1706-1716 (2011).
6. Hozbor, D. et al. Pertussis epidemiology in Argentina: trends over 2004-2007. J. Infect. 59, 225-231 (2009).
7. Quinn, H.E. & McIntyre, P.B. Pertussis epidemiology in Australia over the decade 1995-2005-trends by region and age group. Commun. Dis. Intell. 31, 205-215 (2007).
8. Ntezayabo, B., De Serres, G. & Duval, B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. J. 22, 22-27 (2003).
9. Celentano, L.P. et al. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 24, 761-765 (2005).
10. Friedrich, M.J. Research aims to boost pertussis control. JAMA 306, 27-29 (2011).
11. Witt, M.A., Katz, P.H. & Witt, D.J. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin. Infect. Dis. 54, 1730-1735 (2012).
12. Elahi, S., Holmstrom, J. & Gerdts, V. The benefits of using diverse animal models for studying pertussis. Trends Microbiol. 15, 462-468 (2007).
13. Warfel, J.M., Beren, J., Kelly, V.K., Lee, G. & Merkel, T.J. Nonhuman primate model of pertussis. Infect. Immun. 80, 1530-1536 (2012).
14. Warfel, J.M., Beren, J. & Merkel, T.J. Airborne Transmission of Bordetella pertussis. J. Infect. Dis. 206, 902-906 (2012).
15. Higgs, R., Higgins, S.C., Ross, P.J. & Mills, K.H. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal. Immunol. 5, 485-500 (2012).
16. Leef, M., Elkins, K.L., Barbic, J. & Shahin, R.D. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J. Exp. Med. 191, 1841-1852 (2000).
17. Kolls, J.K. & Khader, S.A. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev. 21, 443-448 (2010).
18. Iwakura, Y., Nakae, S., Saijo, S. & Ishigame, H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226, 57-79 (2008).
19. Cua, D.J. & Tato, CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489 (2010).
20. Zielinski, CE. et al. Pathogen-induced human TH17 cells produce IFN-g or IL-10 and are regulated by IL-1b. Nature 484, 514-518 (2012).
21. McGeachy, M.J. & Cua, D.J. Th17 cell differentiation: the long and winding road. Immunity 28, 445-453 (2008).
22. Caccamo, N. et al. Differentiation, phenotype, and function of interleukin-17-producing human Vg9Vd2 T cells. Blood 118, 129-138 (2011).
23. Pitcher, C.J. et al. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168, 29-43 (2002).
24. Wei, S., Zhao, E., Kryczek, I. & Zou, W. Th17 cells have stem cell-like features and promote long-term immunity. Oncoimmunology 1, 516-519 (2012).
25. Ye, P. et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25, 335-340 (2001).
26. Khader, S.A. et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4 + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8, 369-377 (2007).
27. Cohen, J.M.et al. Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation. PLoS One 6, e25558 (2011).
28. Ghoreschi, K., Laurence, A., Yang, X.P., Hirahara, K. & O'Shea, J.J. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 32, 395-401 (2011).
29. Happel, K.I. etal. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
30. Park, H. et al. A distinct lineage of CD4Tcells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
31. Onishi, R.M. & Gaffen, S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129, 311-321 (2010).
32. Kryczek, I. et al. Human TH17 cells are long-lived effector memory cells. Sci. Transl. Med. 3, 104ra100 (2011).
33. Zhang, X., Goel, T., Goodfield, L.L., Muse, S.J. & Harvill, E.T. Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/-mice. J. Immunol. 186, 4895-4904 (2011).
34. Zhang, X. etal. Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection-or vaccination-induced immunity against Bordetella pertussis. Infect. Immun. 79, 527-541 (2011).
35. Dunne, A. et al. Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis. J. Immunol. 185, 1711-1719 (2010).
36. Andreasen, C, Powell, D.A. & Carbonetti, N.H. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 4, e7079 (2009).
37. Ryan, M. et al. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J. Infect. Dis. 175, 1246-1250 (1997).
38. Mascart, F. et al. Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. J Immunol 170, 1504-1509 (2003).
39. Hafler, J.P. & Pohl-Koppe, A. The cellular immune response to Bordetella pertussis in two children with whooping cough. Eur. J. Med. Res. 3, 523-526 (1998).
40. Watford, W.T., Moriguchi, M., Morinobu, A. & O'Shea, J.J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14, 361-368 (2003).
41. Fedele, G. et al. Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression. Infect. Immun. 73, 1590-1597 (2005).
42. Fedele, G. et al. Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways. PLoS One 5, e8734 (2010).
43. Moffitt, K.L. et al. T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe. 9, 158-165 (2011).
44. Brereton, C.F. et al. Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production. J. Immunol. 186, 5896-5906 (2011).
45. Higgins, S.C., Jarnicki, A.G., Lavelle, E.C. & Mills, K.H. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177, 7980-7989 (2006).
46. Ryan, M. etal. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93, 1-10 1998).
47. Dirix, V. et al. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy. Vaccine 27, 6042-6047 (2009).
48. White, O.J. et al. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 28, 2648-2652 (2010).
49. Ausiello, C.M., Urbani, F., laSala, A., Lande, R. & Cassone, A. Vaccine-and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65, 2168-2174 (1997).